MATERIALS AND METHODS
SECONDARY
This was an analysis of secondary outcomes in the Morbidity/Resistance substudy of the MORDOR I trial, which has been previously detailed.Nasopharyngeal swabs were tested for respiratory pathogens and numerous serotypes of The total number of positive swabs was calculated using the median and interquartile range (IQR) of the village prevalence. To quantify pathogen burden, we calculated the frequency of nasal swab positivity and average quantity of seven respiratory pathogens (